Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Boyd

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Neoplasia (New York, N.Y.)|March 10, 2015
Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcomeJoyce N Barlin, Qin C Zhou, Mario M Leitao, et al.
The Journal of Clinical Investigation|January 6, 2006
Differential exoprotease activities confer tumor-specific serum peptidome patternsJosep Villanueva, David R Shaffer, John Philip, et al.
Cancer Research|March 17, 2006
10th Biennial Helene Harris Memorial Trust meetingFrances R Balkwill, Alan Ashworth, Robert C Bast, et al.
Autophagy|January 6, 2017
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancerNúria Eritja, Bo-Juen Chen, Ruth Rodríguez-Barrueco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.
Human Mutation|July 12, 2002
Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutationsIrene L Andrulis, Hoda Anton-Culver, Jeanne Beck, et al.
BMC Genetics|February 7, 2008
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotypingAdam B Olshen, Bert Gold, Kirk E Lohmueller, et al.
Cancer Cell|September 10, 2014
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancerXiaowen Hu, Yi Feng, Dongmei Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancerMaura N Dickler, Hope S Rugo, Carey A Eberle, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Neoplasia (New York, N.Y.)|March 10, 2015
Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcomeJoyce N Barlin, Qin C Zhou, Mario M Leitao, et al.
The Journal of Clinical Investigation|January 6, 2006
Differential exoprotease activities confer tumor-specific serum peptidome patternsJosep Villanueva, David R Shaffer, John Philip, et al.
Cancer Research|March 17, 2006
10th Biennial Helene Harris Memorial Trust meetingFrances R Balkwill, Alan Ashworth, Robert C Bast, et al.
Autophagy|January 6, 2017
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancerNúria Eritja, Bo-Juen Chen, Ruth Rodríguez-Barrueco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.
Human Mutation|July 12, 2002
Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutationsIrene L Andrulis, Hoda Anton-Culver, Jeanne Beck, et al.
BMC Genetics|February 7, 2008
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotypingAdam B Olshen, Bert Gold, Kirk E Lohmueller, et al.
Cancer Cell|September 10, 2014
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancerXiaowen Hu, Yi Feng, Dongmei Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancerMaura N Dickler, Hope S Rugo, Carey A Eberle, et al.
Pageof 9